Date Range
Date Range
Date Range
Glucosense Diagnostics is developing a device to directly monitor blood glucose levels without the need to penetrate the skin. The device is under development and not currently available for sale.
GlucoSentient has recently awarded two SBIR Phase I awards for developing point-of-care solution for invasive fungal infections and therapeutic drug monitoring for bipolar disorder. GlucoSentient receives NSF Phase II SBIR grant to continue work on Therapeutic Drug Monitoring. GlucoSentient receives Phase I NIH SBIR award for work in Disease Monitoring.
Thursday, May 9, 2013. Back Pain can be treated to give you relief. When considering back pain we must concern ourselves with its variants. The assessments in medical terms are based on Lumbrosacral, which may include ac.